As European markets continue to rally, with the STOXX Europe 600 Index reaching record levels amid a surge in technology stocks and expectations for lower U.S. borrowing costs, investors are increasingly looking towards growth companies with strong insider ownership as potential opportunities. In this environment, stocks that combine robust growth prospects with significant insider stakes may offer an appealing blend of confidence and alignment between company leadership and shareholders.
Name
Insider Ownership
Earnings Growth
XTPL (WSE:XTP)
23.3%
107.3%
Xbrane Biopharma (OM:XBRANE)
13%
112.0%
Pharma Mar (BME:PHM)
11.9%
44.2%
MedinCell (ENXTPA:MEDCL)
12.5%
90.7%
KebNi (OM:KEBNI B)
36.3%
63.7%
Elliptic Laboratories (OB:ELABS)
24.4%
97.5%
CTT Systems (OM:CTT)
17.5%
37.9%
Circus (XTRA:CA1)
24.5%
67.1%
CD Projekt (WSE:CDR)
29.7%
43.5%
Bonesupport Holding (OM:BONEX)
10.4%
59.4%
Here’s a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nordic Semiconductor ASA is a fabless semiconductor company that develops and sells integrated circuits for short- and long-range wireless applications across Europe, the Americas, and the Asia Pacific, with a market cap of NOK32.47 billion.
Operations: The company’s revenue segment is primarily from the design and sale of integrated circuits and related solutions, amounting to $628.11 million.
Insider Ownership: 10.4%
Nordic Semiconductor’s earnings are forecast to grow significantly at 40.7% annually, outpacing the Norwegian market’s growth rate of 13.5%. Despite a slower revenue growth forecast of 11.7%, it exceeds the market average of 2.7%. The company became profitable this year, reporting USD 164.08 million in Q2 sales and USD 10.14 million net income compared to last year’s loss. Recently, Nordic completed a NOK 1.05 billion equity offering, enhancing its capital base for future expansion efforts.
OB:NOD Ownership Breakdown as at Oct 2025
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Swedencare AB (publ) develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses across North America, Europe, and internationally with a market cap of SEK5.46 billion.
Operations: Swedencare’s revenue is derived from its operations in Europe (SEK557.60 million), production activities (SEK687.30 million), and North America (SEK1.59 billion).